UCB
Rystiggo Approved for gMG in Adults Who Are AChR/MuSK Antibody–Positive
The approval was based on safety and efficacy data from the MycarinG study of Rystiggo in adult patients with gMG.
JUNE 27, 2023
FDA Approves Cimzia for Spondyloarthritis
The first FDA-approved treatment of nr-axSpA “fulfills an unmet need” for a type of arthritis that ...
MARCH 28, 2019
Cimzia Receives New Indication for Moderate to Severe Plaque Psoriasis
The FDA approved a new indication for Cimzia to treat moderate to severe plaque psoriasis in adults.
MAY 30, 2018
Label Change for Cimzia: Negligible Mother-Child Transfer
Some women with chronic inflammatory diseases experience persistent moderate to high disease activity during ...
MARCH 22, 2018
Load more